Premium
Prescribing study reveals undertreatment of ADHD, depression, and anxiety among youth
Publication year - 2018
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30286
Subject(s) - psychiatry , anxiety , depression (economics) , attention deficit hyperactivity disorder , stimulant , antidepressant , psychology , psychopharmacology , child and adolescent psychiatry , clinical psychology , antipsychotic , medicine , schizophrenia (object oriented programming) , economics , macroeconomics
Prescribing patterns of stimulant, antidepressant, and antipsychotic medications to young people are consistent with the epidemiology of anxiety, depression, and attention‐deficit/hyperactivity disorder (ADHD), researchers have found, countering criticism that these medications are overprescribed in children and adolescents. In fact, the study, published in the Journal of Child and Adolescent Psychopharmacology , shows that antidepressants and stimulants are, if anything, underprescribed. However, prescribing of antipsychotics for children may be more difficult to align to indications, as so much of this prescribing is done for off‐label — although not necessarily inappropriate — indications, the researchers concluded.